VLKIM
WST icon

Van Lanschot Kempen Investment Management’s West Pharmaceutical WST Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.9M Sell
51,501
-3,014
-6% -$750K 0.11% 132
2025
Q4 		$15M Buy
+54,515
New +$14.9M 0.13% 125

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Van Lanschot Kempen Investment Management's WST Position: Q1 2026 in Review

Van Lanschot Kempen Investment Management reduced its West Pharmaceutical (WST) stake by 5.5% in Q1 2026, selling an estimated $750K and leaving 51,501 shares worth $12.9M. The position accounts for 0.11% of the portfolio, ranked #132.

Van Lanschot Kempen Investment Management first reported a position in WST in Q4 2025 and has held it in 2 quarters since. The position peaked at $15M in Q4 2025. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Van Lanschot Kempen Investment Management held 51,501 shares of West Pharmaceutical worth $12.9M as of Q1 2026.
  • Van Lanschot Kempen Investment Management sold 3,014 West Pharmaceutical shares in Q1 2026, an estimated $750K.
  • West Pharmaceutical made up 0.11% of Van Lanschot Kempen Investment Management's portfolio in Q1 2026, its #132 holding.
  • Van Lanschot Kempen Investment Management first reported a position in West Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • Van Lanschot Kempen Investment Management's West Pharmaceutical position peaked at $15M in Q4 2025.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.